Am. J. Respir. Crit. Care Med., Volume 156, Number 5, November 1997, 1536-1540

Regional Variability of Lung Inflammation in Cystic Fibrosis

KEITH C. MEYER and ANUJA SHARMA

Department of Medicine, Section of Pulmonary and Critical Care Medicine, University of Wisconsin Medical School, Madison, Wisconsin

Chest radiography in patients with cystic fibrosis (CF) frequently shows more severe changes in the upper lobes. We performed bronchoalveolar lavage (BAL) on 12 clinically stable, young adult patients with CF to determine whether inflammation varies significantly among geographically distinct areas of the lung. We found that absolute numbers of neutrophils were generally greater in BAL fluid from the upper lobe (25.7 ± 7.9 × 10⁵ neutrophils/ml [mean ± SEM]) of the right lung than that obtained from the right lower lobe (6.8 ± 2.8 × 10⁵ neutrophils/ml; p < 0.01). The mean value of unopposed neutrophil elastase activity in upper-lobe BAL fluid (227 ± 91 nmol peptide hydrolyzed/ml/min) was also significantly greater than that in lower-lobe BAL fluid (84 ± 43 nmol/peptide hydrolyzed/ml/ min; p < 0.01), and similar differences were found for myeloperoxidase activity and DNA content. Neutrophil influx and unopposed neutrophil elastase for a given region correlated inversely with lung function or percentage of ideal body weight, and upper- versus lower-lobe differences were more pronounced in subjects with better preservation of lung function. Our findings suggest that regional variation in inflammation must be considered when utilizing BAL to study lower respiratory tract inflammation in CF or to monitor responses to therapeutic interventions that can potentially diminish lung inflammation. Our findings may also have implications for the study of the natural history of lung inflammation and infection in neonates, infants, and young children with CF.

This article has been cited by other articles:

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				S. D. Davis, A. S. Brody, M. J. Emond, L. C. Brumback, and M. Rosenfeld Endpoints for Clinical Trials in Young Children with Cystic Fibrosis Proceedings of the ATS, August 1, 2007; 4(4): 418 - 430. [Abstract] [Full Text] [PDF]

				S. D. Davis, L. A. Fordham, A. S. Brody, T. L. Noah, G. Z. Retsch-Bogart, B. F. Qaqish, B. C. Yankaskas, R. C. Johnson, and M. W. Leigh Computed Tomography Reflects Lower Airway Inflammation and Tracks Changes in Early Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 943 - 950. [Abstract] [Full Text] [PDF]

				T. D. Starner and P. B. McCray Jr. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria Ann Intern Med, December 6, 2005; 143(11): 816 - 822. [Full Text] [PDF]

				N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF]

				K. Paul, E. Rietschel, M. Ballmann, M. Griese, D. Worlitzsch, J. Shute, C. Chen, T. Schink, G. Doring, S. van Koningsbruggen, et al. Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 719 - 725. [Abstract] [Full Text] [PDF]

				D. S. Armstrong In Celebration of Expectoration: Induced Sputum Indices as Outcome Measures in Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1412 - 1413. [Full Text] [PDF]

				R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]

				R. L. Gibson, J. Emerson, S. McNamara, J. L. Burns, M. Rosenfeld, A. Yunker, N. Hamblett, F. Accurso, M. Dovey, P. Hiatt, et al. Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 841 - 849. [Abstract] [Full Text] [PDF]

				M. L. Aitken, K. E. Greene, M. R. Tonelli, J. L. Burns, J. C. Emerson, C. H. Goss, and R. L. Gibson Analysis of Sequential Aliquots of Hypertonic Saline Solution-Induced Sputum From Clinically Stable Patients With Cystic Fibrosis Chest, March 1, 2003; 123(3): 792 - 799. [Abstract] [Full Text] [PDF]

				C. J. DAKIN, A. H. NUMA, H. WANG, J. R. MORTON, C. C. VERTZYAS, and R. L. HENRY Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic Fibrosis Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 904 - 910. [Abstract] [Full Text] [PDF]

				J.P. Gutierrez, K. Grimwood, D.S. Armstrong, J.B. Carlin, R. Carzino, A. Olinsky, C.F. Robertson, and P.D. Phelan Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis Eur. Respir. J., February 1, 2001; 17(2): 281 - 286. [Abstract] [Full Text] [PDF]

				K. C. Meyer, A. Sharma, R. Brown, M. Weatherly, F. R. Moya, J. Lewandoski, and J. J. Zimmerman Function and Composition of Pulmonary Surfactant and Surfactant-Derived Fatty Acid Profiles Are Altered in Young Adults With Cystic Fibrosis Chest, July 1, 2000; 118(1): 164 - 174. [Abstract] [Full Text] [PDF]